Diagnosis and Management of Heart Failure
| Diagnosis and Management of Heart Failure |
| Autore | Gladysheva Inna P |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (202 p.) |
| Soggetto topico |
Cardiovascular medicine
Medicine and Nursing |
| Soggetto non controllato |
24-h ECG monitoring
2D echocardiography acute myocardial infarction adverse left ventricular remodeling angiotensin receptor-neprilysin inhibitor arteriovenous fistulas biomarkers blood biomarkers cardiac allograft vasculopathy cardiopulmonary exercise test cardiovascular disease chronic heart failure chronic kidney disease clinical assessment congestion diagnosis dilated cardiomyopathy E/e' ratio echocardiography edema ejection fraction endothelial dysfunction epicardial fat fatty liver fibrosis fluid management galectin-3 heart failure heart failure readmission heart rate variability heart transplant heart transplant rejection HFrEF hospitalization predictor left atrial strain left ventricle end-diastolic diameter left ventricle outflow tract velocity-time integral left ventricular-arterial coupling longitudinal strain matrix metalloproteinases mortality myocardial infarction n/a NT-proBNP overhydration pacing parameters preserved ejection fraction preserved left ventricular ejection fraction pulmonary hypertension reduced left ventricular ejection fraction risk stratification sensing parameters short-term prognosis soluble ST2 ST-segment elevation myocardial infarction tissue inhibitors of metalloproteinases transthoracic echocardiography type 2 diabetes mellitus ventilatory inefficiency |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576881803321 |
Gladysheva Inna P
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Biomarkers for Heart Disease
| Novel Biomarkers for Heart Disease |
| Autore | Lichtenauer Michael |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (420 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
acute kidney injury
acute myocardial infarction AMI aneurysm aortic disease aortic regurgitation atrial fibrillation atrial myopathy biomarker biomarkers carbohydrate antigen-125 cardiac biomarkers cardiac intensive care units cardiac magnetic resonance imaging cardiometabolic disease cardiometabolic risks cardiovascular death cardiovascular diseases cardiovascular events cardiovascular risk cardiovascular surgery catestatin cell adhesion molecule ceramides ceruloplasmin chronic heart failure chronic kidney disease circulating cells circulating miRNAs CKD cohort studies coronary artery disease CVD diet quality echocardiography ejection fraction epicardial adipose tissue epicardial fat epicardial fat volume FABP3 fatty acid-binding protein 3 Framingham risk score GDF-15 GDF8 growth differentiation factor 15 (GDF-15) H-FABP healthy eating index heart failure heart failure decompensation heart-type fatty acid-binding protein heart-type fatty acid-binding protein (H-FABP) herat failure HF HFpEF HFrEF hypertension inflammatory marker KLF4 left ventricular adverse remodelling left ventricular ejection fraction left ventricular systolic function liver-type fatty-acid-binding protein long-term outcomes longitudinal strain magnetic resonance imaging magnetic resonance spectroscopy metabolic syndrome microRNA miRNA mitochondrial DNA (mtDNA) mitochondrial dysfunction muscle wasting myocardial infarction myocardial triglyceride content myostatin n/a NAFLD NAFLD fibrosis score NT-proBNP NYHA functional class obesity older women operative risk oxidative stress PBMCS Pentraxin-3 platelets PPCI pregnancy-associated plasma protein-A primary prevention reactive oxygen species (ROS) renal dysfunction repeated measurements risk prediction risk stratification saliva salivary biomarkers sarcopenia secondary prevention SOCE soluble suppression of tumorigenicity 2 (sST2) soluble urokinase-type plasminogen activator receptor (suPAR) sST2 STEMI STIM1 sudden cardiac death suPAR synthetic phenotype T1 mapping TGF-β pathway thyroid-stimulating hormone troponin vena contracta area ventricular arrhythmia ventricular tachycardia very low-density lipoprotein |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557546203321 |
Lichtenauer Michael
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||